Picture supply: Getty Pictures
The London Inventory Trade is crammed with loads of profitable alternatives to unlock a second revenue stream. And one which at the moment stands out among the many FTSE 250 is Victrex (LSE:VCT), providing an infinite 8.6% dividend yield. That’s virtually 3 times the three.3% payout supplied by the FTSE 250. And by spending simply over £5,700, traders can snap up 840 shares, including £500 to their passive revenue.
The query now turns into, is Victrex an excellent funding? Or is it a lure that would destroy wealth as a substitute of making it?
Investigating the chance
Let’s begin by digging into a number of the issues Victrex at the moment faces. A giant motive why the corporate’s providing such a excessive payout is as a result of share value tumbling 35% for the reason that begin of 2025.
Victrex has been struggling via a number of operational setbacks recently. Polymer manufacturing volumes have firmly underperformed expectations, notably in China, the place its new manufacturing unit is now solely anticipated to supply 50 tonnes of fabric versus the unique goal of 200 tonnes.
On the identical time, whereas the corporate has efficiently attracted new prospects to its enterprise, not many of those have been after the group’s premium product choices. Subsequently, the group’s common promoting value has suffered, and revenue margins are experiencing higher strain, finally leading to revenue warnings and institutional investor downgrades.
Pairing all this with mounting international commerce tensions and geopolitical dangers that would disrupt provide chains, it’s not stunning to see traders develop extra cautious.
Nevertheless, with the weak sentiment now seemingly already baked into its share value, might the inventory secretly be a discount?
The optimist’s case
Whereas Victrex is undoubtedly coping with a difficult setting, there are nonetheless some encouraging indicators of long-term potential. The agency operates in a comparatively distinctive area of interest with comparatively low ranges of competitors regardless of the essential nature of its polymer merchandise. In spite of everything, they’re used throughout the aerospace, healthcare, electronics, and power industries.
The preliminary launch of its new China facility has actually been underwhelming. Nevertheless it’s nonetheless anticipated to ship a 15% saving to manufacturing prices, permitting administration to cut back the strain on profitability even amongst its non-premium choices.
As such, the newest analyst forecasts venture that earnings ought to rebound in 2026, supplied no extra spanners are thrown into the works. And mixing this upcoming anticipated restoration with a weakened share value might open the door to profitable dividends and capital features over the following 12-24 months.
The underside line
All issues thought-about, Victrex seems to be a high-risk, high-reward funding story in 2025. If administration can restore revenue margins and demand from each healthcare and aerospace prospects is restored, shopping for shares at present might be profitable in the long term. Nevertheless, the corporate has made fairly a number of stumbles of late. So I’m personally conserving it on my watchlist for now. If the group can present extra encouraging indicators {that a} turnaround is beneath method, then taking a better look might be warranted.
